Skip to content

Laser vs Lontophoresis in KOA

Effectiveness of Laser Therapy Versus Lontophoresis in the Management of Knee Osteoarthritis: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07666061
Enrollment
66
Registered
2026-06-24
Start date
2026-08-01
Completion date
2027-04-01
Last updated
2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthritis Osteoarthritis

Brief summary

This randomized controlled trial aims to compare the effectiveness of laser therapy and iontophoresis in patients with knee osteoarthritis. The study will evaluate pain reduction, functional improvement, and knee joint mobility following

Detailed description

Participants will be randomly assigned into three groups receiving either laser therapy plus conventional physiotherapy, iontophoresis plus conventional physiotherapy, or conventional physiotherapy alone. Outcome measures will be assessed before and after treatment

Interventions

DEVICELow-Level Laser Therapy

Low-level laser therapy combined with conventional physical therapy for patients with knee osteoarthritis to reduce pain and improve functional mobility and knee joint range of motion

Iontophoresis using dexamethasone combined with conventional physical therapy for patients with knee osteoarthritis to reduce pain and improve physical function and knee joint mobility

Conventional physical therapy program for patients with knee osteoarthritis including therapeutic exercises, stretching, strengthening exercises, and pain relief modalities to improve knee function and mobility.

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* \* Age 45-65 years. * Diagnosed primary knee osteoarthritis (Grade I-II). * Both genders. * Ability to follow treatment protocol.

Exclusion criteria

* \* Previous knee surgery. * Intra-articular injections within last 6 months. * Pacemaker. * Skin lesions at treatment area. * Severe neurological or cardiovascular disorders.

Design outcomes

Primary

MeasureTime frame
Pain intensity measured using Visual Analogue Scale (VAS)Baseline and after 4 weeks of treatment
Functional disability measured using WOMAC.Baseline and after 4 weeks of treatment
3. Knee Range of Motion (ROM).Baseline and after 4 weeks of treatment

Secondary

MeasureTime frameDescription
Change in physical function assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function SubscaleBaseline (Day 0) and Week 4The WOMAC Physical Function Subscale consists of 17 items assessing difficulty in performing daily activities. Scores range from 0 to 68, with higher scores indicating worse physical function.
2. Reduction of joint stiffness.Baseline and after 4 weeks of treatment
Change in daily activities performance assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function SubscaleBaseline (Day 0) and Week 4The WOMAC Physical Function Subscale consists of 17 items assessing difficulty in activities of daily living. Scores range from 0 to 68, with higher scores indicating worse functional limitation.

Contacts

CONTACTabdulaziz fahad alsulaimani, MASTER
azoztaif88@hotmail.com966566613748
STUDY_CHAIRhane mohamed hamed, PHD

professor of orthopedic surgery depaetment of orthopedic surgery faculty of medicine kafrelsheikh university

STUDY_CHAIRmahmoud mohamed ewida, PHD

professor of basic sciences for physical therapy department of basic sciences for physical therapy faculty oh physical therapy kafrelsheikh university

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 25, 2026